These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 26120067)
1. Cutaneous rash and dapsone-induced hypersensitivity syndrome a common manifestation in adult immune thrombocytopenia. Presentation and outcome in 16 cases. Sauvetre G; MahÉvas M; Limal N; Guillaud C; Khellaf M; Bierling P; Languille L; Delbos F; Noizat-Pirenne F; Michel M; Godeau B Am J Hematol; 2015 Oct; 90(10):E201-2. PubMed ID: 26120067 [No Abstract] [Full Text] [Related]
2. Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. Schiff DE; Roberts WD; Sue YJ J Pediatr Hematol Oncol; 2006 Jun; 28(6):395-8. PubMed ID: 16794511 [TBL] [Abstract][Full Text] [Related]
3. Liver injury, rash, and encephalopathy in a 23-year-old Asian man prescribed dapsone. Wonnaparhown A; Chung C; Shadix S; Patel R; Pandat S; Chinchilla D; Lindgren B; Falk J J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1071-1072. PubMed ID: 30149094 [No Abstract] [Full Text] [Related]
4. Features and Treatment of Dapsone-Induced Hepatitis, Based on Analysis of 44 Cases and Literature Review. Devarbhavi H; Raj S; Joseph T; Singh R; Patil M Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1805-1807. PubMed ID: 28552804 [No Abstract] [Full Text] [Related]
5. Osteonecrosis of the femoral head in a patient with Henoch-Schönlein purpura and drug-induced hypersensitivity syndrome treated with corticosteroids. Hirahara K; Kano Y; Asano Y; Shiohara T Acta Derm Venereol; 2013 Jan; 93(1):85-6. PubMed ID: 22854786 [No Abstract] [Full Text] [Related]
6. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone. Holtzer CD; Flaherty JF; Coleman RL Pharmacotherapy; 1998; 18(4):831-5. PubMed ID: 9692656 [TBL] [Abstract][Full Text] [Related]
7. How does dapsone work in immune thrombocytopenia? Implications for dosing. Hill QA Blood; 2015 Jun; 125(23):3666-8. PubMed ID: 26045596 [No Abstract] [Full Text] [Related]
8. Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases. Mok CC; Lau CS; Wong RW J Rheumatol; 1998 Jun; 25(6):1246-7. PubMed ID: 9632100 [No Abstract] [Full Text] [Related]
10. Dapsone syndrome--first Malaysian paediatric case report. Zurina Z; Elizawaty O; Thevarajah S; Norlijah O Med J Malaysia; 2012 Feb; 67(1):105-7. PubMed ID: 22582558 [TBL] [Abstract][Full Text] [Related]
11. Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum. Seneschal J; Guillet S; Ezzedine K; Taïeb A; Milpied B Dermatology; 2012; 224(2):115-9. PubMed ID: 22508198 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced acute pancreatitis: a rare manifestation of an incomplete "dapsone syndrome". Das AK; Jawed Q Indian J Pharmacol; 2014; 46(4):455-7. PubMed ID: 25097293 [TBL] [Abstract][Full Text] [Related]
13. Dapsone for immune thrombocytopenic purpura in children and adults. Patel AP; Patil AS Platelets; 2015; 26(2):164-7. PubMed ID: 24512442 [TBL] [Abstract][Full Text] [Related]
14. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505 [TBL] [Abstract][Full Text] [Related]
15. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients. Damodar S; Viswabandya A; George B; Mathews V; Chandy M; Srivastava A Eur J Haematol; 2005 Oct; 75(4):328-31. PubMed ID: 16146539 [TBL] [Abstract][Full Text] [Related]
16. Disappointing response to dapsone as second line therapy for primary ITP: a case series. Oo T; Hill QA Ann Hematol; 2015 Jun; 94(6):1053-4. PubMed ID: 25527127 [No Abstract] [Full Text] [Related]